Medication info
Clarisse 250 mg (Clarithromycin)

Clarisse 250 mg (Clarithromycin)

Prescription medicationTabletOral
Ingredient · strength
Clarithromycin›250mg / 1 tablet
Manufacturer / importer
Kunil Pharmaceutical Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199903348 · Approved 1999.03.18 · Insurance code 646802590

Summary

Main use
Treatment of respiratory, skin, and mycobacterial infections; eradication of Helicobacter pylori in duodenal ulcers
Who takes it
Adults · Children
Adult dose
○ Adults: The usual dose is 250mg (potency) of clarithromycin per dose twice daily; for severe infections, administer 500mg (potency) per dose twice daily. The usual treatment duration is 7~14 days. For patients with renal impairment whose creatinine clearance is 30mL/min or less, the dose should be reduced by half: 250mg (potency) once daily, or, for severe infections, 250mg (potency) per dose twice daily. Do not administer this medicine to these patients for more than 14 days. ○ Mycobacterial infections: Administer 500mg (potency) of this medicine per dose twice daily. In this case, it should be administered in combination with other antimycobacterial agents, such as ethambutol, clofazimine, and rifampin. ○ Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer 500mg (potency) of this medicine 3 times daily for 14 days in combination with omeprazole 40mg once daily, followed by omeprazole 40mg once daily for 14 consecutive days. That is, administer clarithromycin 500mg (potency) per dose 3 times daily for 14 days (days 1~14), and omeprazole 40mg once daily for 28 days (days 1~28).
Child dose
○ Children 12 years of age or older: Same as adults ○ For children under 12 years of age, use clarithromycin dry syrup.

Ingredients

Manufacturer
Kunil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory, skin, and mycobacterial infections; eradication of Helicobacter pylori in duodenal ulcers

  • Bronchitis
  • pneumonia
  • pharyngitis
  • sinusitis
  • skin and soft tissue infections
  • mycobacterial infections
  • duodenal ulcer
View approved original text

This medication is effectively used for lower respiratory tract infections such as bronchitis or pneumonia and upper respiratory tract infections like pharyngitis and sinusitis. It also helps in treating skin and soft tissue infections. It can be applied to mycobacterial infections caused by Mycobacterium avium or Mycobacterium intracellular. It is used for the eradication of Helicobacter pylori in duodenal ulcer patients, contributing to symptom relief. This drug responds broadly to various bacterial infections, so therapeutic effects can be expected.

How to take

Adult dose

○ Adults: The usual dose is 250mg (potency) of clarithromycin per dose twice daily; for severe infections, administer 500mg (potency) per dose twice daily. The usual treatment duration is 7~14 days. For patients with renal impairment whose creatinine clearance is 30mL/min or less, the dose should be reduced by half: 250mg (potency) once daily, or, for severe infections, 250mg (potency) per dose twice daily. Do not administer this medicine to these patients for more than 14 days. ○ Mycobacterial infections: Administer 500mg (potency) of this medicine per dose twice daily. In this case, it should be administered in combination with other antimycobacterial agents, such as ethambutol, clofazimine, and rifampin. ○ Eradication of Helicobacter pylori in patients with duodenal ulcers: Administer 500mg (potency) of this medicine 3 times daily for 14 days in combination with omeprazole 40mg once daily, followed by omeprazole 40mg once daily for 14 consecutive days. That is, administer clarithromycin 500mg (potency) per dose 3 times daily for 14 days (days 1~14), and omeprazole 40mg once daily for 28 days (days 1~28).

Child dose

○ Children 12 years of age or older: Same as adults ○ For children under 12 years of age, use clarithromycin dry syrup.

Precautions

This medication should not be used by patients who are allergic to certain ingredients or have had hypersensitivity reactions to macrolide antibiotics. Patients taking certain medications that may affect heart rhythm or those with a history of heart disease should also avoid this drug. Caution is needed for patients with severely impaired liver or kidney function, as the use of this medication may not be appropriate. It is safest not to take this medication during pregnancy or breastfeeding. If any severe allergic reactions, skin rashes, or breathing difficulties occur during treatment, you should immediately stop taking the medication and consult a healthcare professional. Gastrointestinal symptoms such as abdominal pain, diarrhea, or nausea may occur, and if they persist or worsen, you should inform your doctor. This medication may affect liver function; therefore, if symptoms like jaundice, changes in urine color, or itching appear, you must inform your healthcare provider immediately. Caution is also necessary if kidney function is impaired, and you should consult a doctor if any abnormal symptoms arise. This medication has numerous drug interactions, so please inform your healthcare professional of any other medications you are taking. Particularly, caution is needed when taken with some heart medication, anticoagulants, anticonvulsants, and steroids. Symptoms of central nervous system effects such as dizziness, anxiety, insomnia, or hallucinations may occur during treatment, so you should exercise caution. Long-term or high-dose usage may lead to hearing loss or tinnitus, so if there are signs of such symptoms, please consult a physician. Elderly patients should be more cautious as decreased body function may result in higher drug concentrations during medication use. During treatment, you may experience dizziness or decreased concentration while driving or operating machinery, so caution is advised. In case of overdose, gastrointestinal disorders or psychiatric symptoms may occur; immediate medical attention is required.

Side effects

Shock, anaphylactic symptoms, shortness of breath, convulsions, flushing, rash, itching, urticaria, skin erythema, angioedema, joint swelling, drug rash, abdominal distension, nausea, vomiting, dyspepsia, abdominal pain, malaise, flatulence, diarrhea, oral mucosal erosion, upper abdominal pain, thirst, transient tooth discoloration, pancreatitis, increased amylase, taste disturbances, loss of appetite, constipation, discoloration of stools, membrane colitis, hemorrhagic colitis, fever, cough, abnormal chest X-ray, eosinophilia, eosinophilic lung infiltration, interstitial pneumonia, chronic bronchitis, exacerbation of acute maxillary sinusitis, leukopenia, thrombocytopenia, pancytopenia, hemolytic anemia, agranulocytosis, dizziness, depression, loss of taste, loss of smell, anxiety, insomnia, nightmares, tinnitus, confusion, disorientation, hallucinations, psychosis, depersonalization, convulsions, tremors, numbness, behavioral changes, manic behavior, Stevens-Johnson syndrome, toxic epidermal necrolysis, allergic purpura, drug rash (DRESS), jaundice, hepatocyte hepatitis, cholestatic hepatitis, increased liver enzymes, liver dysfunction, liver failure, fulminant hepatitis, elevated AST, elevated ALT, increased γ-GTP, elevated LDH, increased ALP, increased total bilirubin, elevated serum creatinine, elevated BUN, interstitial nephritis, renal failure, rhabdomyolysis, stomatitis, oral mucositis, oral candidiasis, QT prolongation, ventricular tachycardia, Torsades de pointes, fatigue, headache, taste disturbance, hearing loss, paraesthesia, arthralgia, myalgia, olfactory dysfunction, hypoglycemia, tinnitus, auditory impairment, purpuric rash, acute generalized exanthematous pustulosis (AGEP), muscle cramps, musculoskeletal stiffness, myopathy, vasodilation, venous inflammation at injection site, pain at injection site, inflammation at injection site, fever, asthenia, chest pain, chills, fatigue, abnormal albumin-globulin ratio, elevated serum alkaline phosphatase, increased serum lactate dehydrogenase, increased INR, prolonged prothrombin time, urine discoloration, asthma, nasal bleeding, pulmonary embolism, esophagitis, gastroesophageal reflux disease, gastritis, rectal pain, belching, bloating, tongue discoloration, tooth discoloration, vesicular dermatitis, hyperhidrosis, papular rash, acne, Henoch-Schonlein purpura, elevated serum creatinine, elevated blood urea nitrogen, nephritis, venous inflammation at injection site, pain at injection site, inflammation at injection site, fatigue, fever, asthenia, chest pain, chills, fatigue, changes in mental state, obsessive behavior, hypokalemia, hypoxemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. By following these storage guidelines, the effectiveness of the drug can be maintained, and it can be used safely.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.